Continuing Versus New Prescriptions for Sedative-Hypnotic Medications
United States, 2005–2012
Datos Bibliográficos
Objectives. To assess trends in continuing and new prescriptions for sedative-hypnotic medications, including benzodiazepines (BZDs) and non-BZD receptor agonists (nBZRAs). Methods. Data came from the National Ambulatory Medical Care Survey and comprised 287 288 randomly sampled patient visits. Physicians reported medications prescribed and whether they were “continuing” or “new” prescriptions. We assessed trends in continuing BZD, new BZD, continuing nBZRA, and new nBZRA prescriptions from 2005 to 2012. Results. Proportions of visits with continuing prescriptions increased from 3.4% in 2005 to 4.7% in 2012 (P Conclusions. Increased sedative-hypnotic prescribing in recent years may be attributable to long-term growth in continuing prescriptions, rather than new prescriptions. Public Health Implications. Findings call for renewed efforts to limit continuing prescribing of sedative-hypnotics to reduce their use in the population
Ambulatory · Environmental health · Family medicine · Hypnotic · Medical prescription · Population · Psychiatry · Public health · Sedative · Sedative/hypnotic · Internal Medicine · Medicine · Mental Health Treatment and Access · Nursing · Pharmaceutical Practices and Patient Outcomes · Pharmacology · Pharmacy · Sleep and related disorders
Management of Chronic Insomnia Disorder in Adults
Benzodiazepine use and risk of dementia
A Comprehensive Approach to Address the Prescription Opioid Epidemic in Washington State
Longitudinal Effects of Universal Preventive Intervention on Prescription Drug Misuse
Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996–2013
| Obras citantes distintas | 1 |
|---|---|
| Citas por año | 0,14 |
| Intervalo de citas | 2019 - 2019 (1) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 1 |